House Oversight Committee Chairman James Comer (R-KY). Photo: Christine Schiffner/ALM

A House panel this week advanced a bipartisan bill that would ban pharmacy benefit managers from charging fees based on drug list prices. The House Committee on Oversight and Accountability voted 29-11 to approve the so-called Delinking Revenue from Unfair Gouging (DRUG) Act.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Cost-Containment
Employee Participation
Employee-Paid
Employer-Paid